Welcome to the New Nuclear Medicine Technologist Section, providing you access to everything you need on the SNMMI website in one place.
The nuclear medicine and molecular imaging technologists are highly specialized healthcare professionals who works closely with the nuclear medicine physician. Some of the technologist’s primary responsibilities are to: Prepare and administer radioactive chemical compounds, known as radiopharmaceuticals and to administer adjunctive medications in order to perform patient imaging procedures using sophisticated instrumentation; Process data and enhance digital images using advanced computer technology; Provide images, data analysis, and patient information to the physician for diagnostic interpretation; and Evaluate new procedures for appropriateness in specific clinical settings and patient populations.
The Society of Nuclear Medicine and Molecular Imaging Technologist Section as part of the SNMMI, is constantly striving to make a difference in the way nuclear medicine and molecular imaging technologists receive academic and continuing education as well as information concerning new procedures, technologies and equipment. Research has been a vital part of SNMMI-TS activities for many years, as has monitoring federal regulation and influencing decisions that affect the practice of nuclear medicine.
In addition to providing discussion forums and publishing journals, newsletters and books, SNMMI-TS also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new scientific advances. The activities of the SNMMI-TS National Council of Representatives, volunteer committee members, and staff focus on improving the quality of care for the patients served by technologists around the world.
Learn more about Nuclear Medicine and Molecular Imaging Technologists.
SNMMI educational programs are designed to meet the professional development needs of technologists in the field of nuclear medicine and molecular imaging, as well as providing them with continuing education credit opportunities. SNMMI is an ARRT-recognized conitinuing education mechanism (RCEEMs) provider through the Society's Verification Of Involvement in Continuing Education (VOICE) program.
The profession of nuclear medicine and molecular imaging has evolved over the past several years, and continues to evolve to include imaging and therapy beyond the sole use of radioactive materials. Fusion imaging, combining traditional nuclear medicine with other imaging technologies like CT and MRI and their related contrast agents, as well as new and exciting areas like fluorescence imaging are examples of this. ‘Molecular imaging and therapy’ is a phrase which has been developed in recognition of this expansion. As such, the SNMMI-TS has embraced this evolution with a vision of being the recognized leader in this exciting and ever-growing arena.
The SNMMI-TS offers several professional advancement opportunities, including the SNMMI-TS Leadership Academy and Porfessional Development Awards and Scholarships. Learn more.
In addition, there are several advanced degree programs and certifications available to the nuclear medicine technologist. Specific areas include; the Nuclear Medicine Advanced Associate (masters degree and certification), PET Certification Exam, CT Certification Exam and NCT Certification Exam. Learn more about these and other opportunities.
The spectrum of responsibilities for a nuclear medicine technologist varies widely across the United States. Practice components presented in this document provide a basis for establishing the areas of knowledge and performance for the nuclear medicine technologist. The nuclear medicine technologist must be in compliance with all federal, state, and institutional guidelines, including proper documentation of initial and continued competency in those practices and activities.
Continuing education is a necessary component in maintaining the skills required to perform all duties and tasks of the nuclear medicine technologist in this ever-evolving field.
The Nuclear Medicine Technologist Scope of Practice and Performance Standards document is intended to set forth the standards in important areas of the nuclear medicine technologist’s responsibilities. It may not cover all areas which may present themselves in actual practice. These standards do not supersede the judgment of the individual nuclear medicine technologist and other healthcare professionals serving the patient in light of all of the facts of the individual case. THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING AND THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING TECHNOLOGIST SECTION DISCLAIM ALL LIABILITY ARISING FROM USE OF THESE DOCUMENTS.
The SNMMI-TS has a robust grants and awards program sponsored in part by the Education and Research Foundation (ERF). The numerous grants and awards offered spam from financial assistance for tuition for advanced degree programs, travel awards to attend the annual meeting, best abstract awards for abstracts presented during the annual meeting, clinical advancement awards and the leadership academy.
The SNMMI & SNMMI-TS Grants and Awards Committees are proud to announce that SNMMI has transitioned away from paper and will only be accepting online applications again in 2013!
Click here to learn more about all of the available SNMMI-TS awards and to review past award winners.
Visit SNMMI's Career Center.
There are two main questions that remain on the minds of those evaluating PET/MR for clinical practice: Is PET/CT just as good? If yes, isn’t PET/CT cheaper?
(SNMMI in the News)
A treatment strategy for colon cancer combining molecular imaging, a radioimmunotherapy that seeks colon-specific anatomy and concomitant chemotherapy is being bundled as chemoradiotherapy to take out more metastatic disease, according to a study published online Feb. 20 in the Journal of Nuclear Medicine.
(SNMMI in the News)
“Alzheimer’s disease is probably the most underfunded disease in the U.S.,” charges Dean M. Hartley, PhD, director of science initiatives, medical and scientific relations, for the Alzheimer’s Association. It’s not only the disproportionate funding that has Alzheimer’s stakeholders up in arms. The July 2013 draft decision by CMS to limit reimbursement for florbetapir PET to coverage with evidence development represents a potentially devastating blow to the dissemination of amyloid PET imaging.
(SNMMI in the News)
Researchers from the University of Manchester have shown promising results for a new treatment approach in follicular lymphoma, a type of non-Hodgkin’s lymphoma.
(MI: Making a Difference)
Just Released! Quick Reference Protocol Manual for Nuclear Medicine Technologists
Targeting technologists specifically, this manual is designed to be a quick reference for technologists to aid in performing the most common nuclear medicine procedures ordered by a referring physician.
Purchase your copy today!